THURSDAY, June 27, 2024 -- For children with eosinophilic esophagitis, dupilumab results in a significantly higher percentage of histologic remission,...

MONDAY, July 1, 2024 -- A liberal transfusion strategy does not reduce the risk of unfavorable neurologic outcome at six months among critically ill...

THURSDAY, June 20, 2024 -- Large language model-based solutions can enhance clinical trial screening performance and reduce costs by automating the...

FRIDAY, June 28, 2024 -- Patients with severe asthma initiating biologics exhibit clinical responses and super-responses, but 40 to 50 percent do not...

TUESDAY, June 18, 2024 -- A multimodal intervention trial implementing evidence-based practice strategies does not reduce opioid overdose deaths,...

WEDNESDAY, June 26, 2024 -- For patients with obesity-related heart failure with preserved ejection fraction (HFpEF), semaglutide reduces body weight...

THURSDAY, June 20, 2024 -- Reteplase is noninferior to alteplase for patients with ischemic stroke within 4.5 hours after symptom onset, according to...

WEDNESDAY, June 26, 2024 -- Reported symptoms are a more accurate indicator of concussion than the 10-word component Standardized Assessment of...

THURSDAY, June 20, 2024 -- Cognitive impairment is delayed among persons who are heterozygous for the apolipoprotein E3 Christchurch variant...

WEDNESDAY, June 26, 2024 -- For patients with chronic migraine (CM), with and without medication overuse, atogepant is efficacious, according to a...